No current peripheral neuropathy > grade at time of randomization Grade or greater peripheral neuropathy Peripheral neuropathy Grade ? Peripheral neuropathy of any etiology that exceeds grade =< grade peripheral neuropathy RE-REGISTRATION ELIGIBILITY CRITERIA (STEP ): =< grade peripheral neuropathy Peripheral neuropathy >= Grade >= peripheral neuropathy Peripheral neuropathy ? Grade . Grade >= peripheral neuropathy at the present time Peripheral neuropathy of Grade within weeks prior to the first study therapy Peripheral neuropathy ?grade . Grade or greater peripheral neuropathy Peripheral neuropathy >= grade at screening Peripheral neuropathy > Grade despite supportive therapy. Peripheral neuropathy of severity greater than grade Peripheral neuropathy greater than or equal to Grade Participants with >= grade peripheral neuropathy Baseline peripheral neuropathy of severity > grade Presence of >= grade peripheral neuropathy Peripheral neuropathy >= grade Presence of peripheral neuropathy > grade Peripheral neuropathy =< grade at the time of registration Presence of > grade peripheral neuropathy Peripheral neuropathy >Grade Grade >= peripheral neuropathy Peripheral neuropathy > grade Clinically significant (>= grade ) peripheral neuropathy at the time of study entry Peripheral neuropathy grade > Peripheral neuropathy > grade , except for grade without limitations on instrumental daily life activities; Has greater than Grade peripheral sensory neuropathy or > Grade peripheral motor neuropathy graded according to the Modified (\Balis\) Pediatric Scale of Peripheral Neuropathies. Active >= grade peripheral neuropathy Peripheral neuropathy > grade Peripheral neuropathy grade or less. No peripheral neuropathy Baseline grade II peripheral neuropathy Current peripheral neuropathy >= grade Peripheral neuropathy >= grade at screening Peripheral neuropathy grade or greater Participants with baseline peripheral neuropathy greater than grade Peripheral neuropathy >= grade Baseline grade II peripheral neuropathy ENTRECTINIB EXCLUSION CRITERIA: Peripheral neuropathy >= grade Grade >= peripheral neuropathy at baseline (within days prior to cycle day ) No peripheral edema >= grade at baseline No peripheral neuropathy >= grade at baseline Peripheral neuropathy, if present, should be =< grade Peripheral neuropathy > grade if due to brentuximab vedotin or any peripheral neuropathy > grade Peripheral neuropathy grade - Peripheral neuropathy > grade Peripheral neuropathy >= grade Has > Grade peripheral sensory neuropathy or > Grade peripheral motor neuropathy graded according to the Modified (\Balis\) Pediatric Scale of Peripheral Neuropathies Has history of Grade or greater peripheral neuropathy during the months prior to enrollment. Patient with peripheral neuropathy Grade > Grade >= peripheral neuropathy Grade >= peripheral neuropathy >= grade peripheral neuropathy Peripheral neuropathy >= grade despite supportive therapy Central nervous system (CNS) toxicity including peripheral neuropathy =< grade Peripheral neuropathy of severity greater than grade Greater than grade peripheral neuropathy at baseline Peripheral neuropathy >= grade at baseline OR peripheral neuropathy >= grade I with neuropathic pain Grade > peripheral neuropathy at baseline (within days prior to cycle day ) Subject has >= grade peripheral neuropathy Peripheral neuropathy >= grade Patients with > grade peripheral sensory neuropathy or > grade peripheral motor neuropathy graded according to the Modified (Balis) Pediatric Scale of Peripheral Neuropathies are not eligible Peripheral neuropathy >= grade Peripheral neuropathy >= grade Peripheral neuropathy =< grade >= grade peripheral neuropathy >= grade peripheral neuropathy within days before beginning maintenance therapy Peripheral neuropathy grade or greater Has peripheral neuropathy ? Grade . Peripheral neuropathy =< grade Has peripheral neuropathy ? Grade Subjects with baseline peripheral neuropathy that exceeds grade Significant symptoms (grade >= ) peripheral neuropathy Peripheral neuropathy ? Grade or ? Grade with pain within weeks prior to first dose Peripheral neuropathy ? Grade Peripheral neuropathy ? Grade . Has peripheral neuropathy ? Grade Current Grade > peripheral neuropathy Grade ? peripheral neuropathy Equal to or greater than grade ataxia, cranial or peripheral neuropathy Peripheral neuropathy < grade Grade >= peripheral neuropathy Current Grade > peripheral neuropathy from any cause Peripheral neuropathy exclusions ? Grade peripheral neuropathy Baseline peripheral neuropathy/paresthesia grade >= Patient has >= grade peripheral neuropathy Patient has >= grade peripheral neuropathy Serious peripheral neuropathy. Peripheral neuropathy- grade or greater Peripheral neuropathy ? Grade . Peripheral neuropathy grade or greater Participants who have more than grade peripheral neuropathy Peripheral neuropathy >= grade Peripheral neuropathy < grade Clinically significant peripheral neuropathy Has baseline peripheral neuropathy/paresthesia grade ? . Evidence of peripheral neuropathy of Grade >. Subject has peripheral neuropathy ? grade . Peripheral neuropathy >= grade Equal to or greater than grade ataxia, cranial or peripheral neuropathy Grade or above peripheral neuropathy Peripheral neuropathy: must be =< grade Grade > peripheral neuropathy at baseline Grade >= peripheral neuropathy within days prior to cycle day Peripheral neuropathy =< grade at the time of registration The patient has peripheral neuropathy >= grade Grade >= peripheral neuropathy within days prior to initiation of therapy Subject has peripheral neuropathy >= grade . Peripheral neuropathy ? Grade despite supportive therapy Has baseline peripheral neuropathy/paresthesia Peripheral neuropathy > Grade . Patient has >= grade peripheral neuropathy Peripheral neuropathy greater than Grade Peripheral neuropathy >= grade at baseline OR peripheral neuropathy >= grade I with neuropathic pain No peripheral neuropathy greater than grade , due to any cause Peripheral neuropathy: must be =< grade Grade or more peripheral neuropathy Peripheral neuropathy ? Grade Peripheral neuropathy >= grade No ? grade peripheral neuropathy. Peripheral neuropathy =< grade Peripheral neuropathy >= grade (Gr) II Peripheral neuropathy =< grade Grade peripheral neuropathy Patient has >= grade peripheral neuropathy Peripheral neuropathy Peripheral neuropathy > grade > grade peripheral neuropathy at baseline Peripheral neuropathy of grade or greater Presence of ? Grade peripheral neuropathy Peripheral neuropathy ? Grade . Presence of clinically significant non-hematological toxicity of prior chemotherapy that has not resolved to ? Grade as determined by CTCAE v ., with the exception of alopecia and peripheral neuropathy. Note: Peripheral neuropathy > Grade plus pain, or Grade or Grade are excluded. Presence of > Grade peripheral neuropathy Peripheral neuropathy ? Grade Peripheral edema > grade Baseline peripheral neuropathy ? grade . Peripheral neuropathy ? grade . Grade >= peripheral neuropathy Peripheral neuropathy greater than grade Evidence of peripheral neuropathy of Grade > Subjects with > grade peripheral neuropathy Peripheral neuropathy Grade >/= Presence of peripheral neuropathy Subjects with Grade > peripheral neuropathy Peripheral neuropathy at study entry Ongoing Grade or Grade peripheral neuropathy, or Grade peripheral neuropathy with pain despite appropriate interventions, within days prior to first dose of study treatment. No grade >= peripheral neuropathy Patient has >= grade peripheral neuropathy Grade >= peripheral neuropathy Baseline peripheral edema >= grade Peripheral neuropathy ?Grade . >= grade peripheral neuropathy Peripheral neuropathy Current Grade > peripheral neuropathy History of peripheral neuropathy; (note: this does not apply to Cohort ) Grade >= peripheral neuropathy Grade ? peripheral neuropathy at baseline (within days prior to cycle day ). Grade or greater peripheral neuropathy Peripheral neuropathy >= grade Peripheral neuropathy that is greater or equal to Grade Has peripheral neuropathy that is greater or equal to Grade Patient has > Grade painful neuropathy or peripheral neuropathy Peripheral neuropathy ? Grade The participant has any Grade (or greater) peripheral neuropathy. No grade or greater peripheral neuropathy. History of peripheral neuropathy of ?grade Peripheral neuropathy of > grade severity. Peripheral neuropathy with grade =< Clinically significant (>= grade ) peripheral neuropathy at the time of study entry Peripheral neuropathy >= grade Grade >= peripheral neuropathy Any peripheral neuropathy >= grade Grade III or IV upper extremity peripheral neuropathy History of peripheral neuropathy prior to receiving neurotoxic chemotherapy Pain or symptoms of peripheral neuropathy of > month's duration attributed to chemotherapy-induced peripheral neuropathy Peripheral neuropathy greater than or equal to grade . No >= grade peripheral neuropathy Peripheral neuropathy ? grade Peripheral neuropathy greater than grade Peripheral neuropathy greater than grade